Cargando…
Gelatin versus its two major degradation products, prolyl‐hydroxyproline and glycine, as supportive therapy in experimental colitis in mice
Gelatin is an anti‐inflammatory dietary component, and its predominant metabolites entering circulation are prolyl‐hydroxyproline (Pro‐Hyp) and glycine. We evaluated the protective effects of orally administered gelatin, glycine, and Pro‐Hyp 10:3:0.8 (w/w/w) against dextran sodium sulfate (DSS)‐indu...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021736/ https://www.ncbi.nlm.nih.gov/pubmed/29983966 http://dx.doi.org/10.1002/fsn3.639 |
_version_ | 1783335526582976512 |
---|---|
author | Zhu, Suqin Huang, Min Feng, Guangxin Miao, Yu Wu, Haohao Zeng, Mingyong Lo, Yangming Martin |
author_facet | Zhu, Suqin Huang, Min Feng, Guangxin Miao, Yu Wu, Haohao Zeng, Mingyong Lo, Yangming Martin |
author_sort | Zhu, Suqin |
collection | PubMed |
description | Gelatin is an anti‐inflammatory dietary component, and its predominant metabolites entering circulation are prolyl‐hydroxyproline (Pro‐Hyp) and glycine. We evaluated the protective effects of orally administered gelatin, glycine, and Pro‐Hyp 10:3:0.8 (w/w/w) against dextran sodium sulfate (DSS)‐induced colitis in mice. According to clinical, histological, and biochemical parameters, they exhibited significant activities in the order of gelatin < glycine < Pro‐Hyp. Gelatin prevented the DSS‐induced increase in interleukin‐1β (IL‐1β), interleukin‐6 (IL‐6), and tumor necrosis factor‐α (TNF‐α) in the colon, rather than in peripheral blood. Glycine and Pro‐Hyp attenuated the DSS‐induced rise in colonic IL‐6 and TNF‐α, as well as peripheral IL‐1β, IL‐6, and TNF‐α. Hematologic results show the attenuation of DSS‐induced leukocytosis and lymphocytosis by glycine and Pro‐Hyp, rather than gelatin. These findings suggest that glycine and Pro‐Hyp constitute the material basis for gelatin's anticolitis efficacy, and they have better anticolitis activities and distinct mechanisms of action when ingested as free compounds than as part of gelatin. |
format | Online Article Text |
id | pubmed-6021736 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-60217362018-07-06 Gelatin versus its two major degradation products, prolyl‐hydroxyproline and glycine, as supportive therapy in experimental colitis in mice Zhu, Suqin Huang, Min Feng, Guangxin Miao, Yu Wu, Haohao Zeng, Mingyong Lo, Yangming Martin Food Sci Nutr Original Research Gelatin is an anti‐inflammatory dietary component, and its predominant metabolites entering circulation are prolyl‐hydroxyproline (Pro‐Hyp) and glycine. We evaluated the protective effects of orally administered gelatin, glycine, and Pro‐Hyp 10:3:0.8 (w/w/w) against dextran sodium sulfate (DSS)‐induced colitis in mice. According to clinical, histological, and biochemical parameters, they exhibited significant activities in the order of gelatin < glycine < Pro‐Hyp. Gelatin prevented the DSS‐induced increase in interleukin‐1β (IL‐1β), interleukin‐6 (IL‐6), and tumor necrosis factor‐α (TNF‐α) in the colon, rather than in peripheral blood. Glycine and Pro‐Hyp attenuated the DSS‐induced rise in colonic IL‐6 and TNF‐α, as well as peripheral IL‐1β, IL‐6, and TNF‐α. Hematologic results show the attenuation of DSS‐induced leukocytosis and lymphocytosis by glycine and Pro‐Hyp, rather than gelatin. These findings suggest that glycine and Pro‐Hyp constitute the material basis for gelatin's anticolitis efficacy, and they have better anticolitis activities and distinct mechanisms of action when ingested as free compounds than as part of gelatin. John Wiley and Sons Inc. 2018-04-16 /pmc/articles/PMC6021736/ /pubmed/29983966 http://dx.doi.org/10.1002/fsn3.639 Text en © 2018 The Authors. Food Science & Nutrition published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Zhu, Suqin Huang, Min Feng, Guangxin Miao, Yu Wu, Haohao Zeng, Mingyong Lo, Yangming Martin Gelatin versus its two major degradation products, prolyl‐hydroxyproline and glycine, as supportive therapy in experimental colitis in mice |
title | Gelatin versus its two major degradation products, prolyl‐hydroxyproline and glycine, as supportive therapy in experimental colitis in mice |
title_full | Gelatin versus its two major degradation products, prolyl‐hydroxyproline and glycine, as supportive therapy in experimental colitis in mice |
title_fullStr | Gelatin versus its two major degradation products, prolyl‐hydroxyproline and glycine, as supportive therapy in experimental colitis in mice |
title_full_unstemmed | Gelatin versus its two major degradation products, prolyl‐hydroxyproline and glycine, as supportive therapy in experimental colitis in mice |
title_short | Gelatin versus its two major degradation products, prolyl‐hydroxyproline and glycine, as supportive therapy in experimental colitis in mice |
title_sort | gelatin versus its two major degradation products, prolyl‐hydroxyproline and glycine, as supportive therapy in experimental colitis in mice |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021736/ https://www.ncbi.nlm.nih.gov/pubmed/29983966 http://dx.doi.org/10.1002/fsn3.639 |
work_keys_str_mv | AT zhusuqin gelatinversusitstwomajordegradationproductsprolylhydroxyprolineandglycineassupportivetherapyinexperimentalcolitisinmice AT huangmin gelatinversusitstwomajordegradationproductsprolylhydroxyprolineandglycineassupportivetherapyinexperimentalcolitisinmice AT fengguangxin gelatinversusitstwomajordegradationproductsprolylhydroxyprolineandglycineassupportivetherapyinexperimentalcolitisinmice AT miaoyu gelatinversusitstwomajordegradationproductsprolylhydroxyprolineandglycineassupportivetherapyinexperimentalcolitisinmice AT wuhaohao gelatinversusitstwomajordegradationproductsprolylhydroxyprolineandglycineassupportivetherapyinexperimentalcolitisinmice AT zengmingyong gelatinversusitstwomajordegradationproductsprolylhydroxyprolineandglycineassupportivetherapyinexperimentalcolitisinmice AT loyangmingmartin gelatinversusitstwomajordegradationproductsprolylhydroxyprolineandglycineassupportivetherapyinexperimentalcolitisinmice |